Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma

CardioVascular and Interventional Radiology

Volumn 35, Issue 6, 2012, Pages 1480-1487

  Deneve, Jeremiah L ^a   Choi, Junsung ^a   Gonzalez, Ricardo J ^a   Conley, Anthony P ^a   Stewart, Steven ^a   Han, Dale ^a   Werner, Philip ^a   Chaudhry, Tariq A ^a   Zager, Jonathan S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chemosaturation; Liver tumors; Metastasis; Percutaneous hepatic perfusion; Sarcoma

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ANGIOGRAPHY; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CASE REPORT; CHEMOSATURATION WITH PERCUTANEOUS HEPATIC PERFUSION; CLINICAL FEATURE; COIL EMBOLIZATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROENTEROLOGICAL PROCEDURE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LEIOMYOSARCOMA; LIVER BIOPSY; LIVER METASTASIS; LYMPHADENOPATHY; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SUPRACLAVICULAR LYMPHADENOPATHY; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; ARTICLE; ARTIFICIAL EMBOLISM; BIOPSY; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; INTRADERMAL DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REGIONAL PERFUSION;

ADMINISTRATION, CUTANEOUS; AGED; ANGIOGRAPHY; BIOPSY; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LEIOMYOSARCOMA; LIVER NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SIGMOID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878232309     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0425-x     Document Type: Conference Paper

References (21)

1. Jaques DP, Coit DG, Casper ES, Brennan MF (1995) Hepatic metastases from soft-tissue sarcoma. Ann Surg 221:392-397
2. Van Glabbeke M, van Oosterom AT, Oosterhuis JW et al (1999) Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 17:150-157
3. DeMatteo RP, Shah A, Fong Y et al (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234:540-547
4. Groeschl RT, Nachmany I, Steel JL et al (2012) Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 214:769-777
5. Park YS, Kim JH, Kim KW et al (2009) Primary hepatic angiosarcoma: imaging findings and palliative treatment with transcatheter arterial chemoembolization or embolization. Clin Radiol 64:779-785
6. Subbiah V, Murthy R, Anderson PM (2011) [90]Yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. J Clin Oncol 29:e292-e294
7. 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic). Indian J Cancer 48:18-23
8. Jones RL, McCall J, Adam A et al (2010) Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma. Eur J Surg Oncol 36:477-482
9. Husted TL, Neff G, Thomas MJ et al (2006) Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant 6:392-397
10. Pingpank JF, Hughes MS, Alexander HR et al (2010) A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma. J Clin Oncol 28(18 suppl):LBA8512
11. Pingpank JF, Libutti SK, Chang R et al (2005) Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol 23:3465-3474
12. Miao N, Pingpank JF, Alexander HR et al (2008) Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations. Ann Surg Oncol 15:815-823
13. Hughes M, Royal RE, Alexander HR et al (2011) Chemosaturation with percutaneous hepatic perfusion (CS-PHP) using melphalan for unresectable neuroendocrine tumor liver metastases (MNET): NCT 00096083. Presented at European Multidisciplinary Cancer Congress, ECC-ESMO, Abstract 6621
14. Ausman RK (1961) Development of a technic for isolated perfusion of the liver. N Y State J Med 61:3993-3997
15. Alexander HR Jr, Libutti SK, Pingpank JF et al (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138-144
16. Alexander HR Jr, Bartlett DL, Libutti SK (2000) Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. Oncologist 5:416-424
17. Farma JM, Pingpank JF, Alexander HR (2006) Isolated hepatic perfusion: treating unresectable liver metastases. Adv Exp Med Biol 574:1-16
18. Savier E, Azoulay D, Huguet E et al (2003) Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg 138:325-332
19. Curley SA, Byrd DR, Newman RA et al (1993) Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery 114:579-585
20. Grover A, Alexander HR Jr (2004) The past decade of experience with isolated hepatic perfusion. Oncologist 9:653-664
21. Curley SA, Newman RA, Dougherty TB et al (1994) Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol 1:389-399